Net Cash Provided by (Used in) Financing Activities in USD of Protagonist Therapeutics, Inc from 2015 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Protagonist Therapeutics, Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2015 to Q1 2025.
  • Protagonist Therapeutics, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $11.4M, a 59% increase year-over-year.
  • Protagonist Therapeutics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $25.9M, a 84.8% decline from 2023.
  • Protagonist Therapeutics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $170M, a 805% increase from 2022.
  • Protagonist Therapeutics, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $18.8M, a 85.5% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Protagonist Therapeutics, Inc Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $11.4M +$4.24M +59% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $7.2M -$19.3M -72.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 $26.5M +$9.54M +56.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $16.9M +$15.9M +1629% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $979K +$580K +145% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $399K +$9K +2.31% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 $390K -$140K -26.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $530K +$156K +41.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $374K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09

Protagonist Therapeutics, Inc Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $25.9M -$145M -84.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-21
2023 $170M +$152M +805% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-21
2022 $18.8M -$111M -85.5% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-21
2021 $130M -$118M -47.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $248M +$202M +438% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 $46M +$21.9M +90.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $24.1M -$41.4M -63.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-10
2017 $65.6M -$40.8M -38.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
2016 $106M +$88.9M +510% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 $17.4M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.